Table 1.

A checklist to monitor psoriasis patients for cardiovascular risk factors.

Measure	Recommendation by the American Heart Association³⁴	American Journal of Cardiology editor consensus³⁵
Blood pressure	Evaluate at least every 2 years	< 140/90 mm Hg in all patients with psoriasis and ≤ 2 major risk factors for CAD
	Target < 120/80 mm Hg	< 130/80 mm Hg in patients with previous CVD, diabetes mellitus, chronic renal disease, or ≥ 3 major risk factors
Body mass index	Evaluate at least every 2 years Target < 25 kg/m²	Not addressed
Waist circumference	Evaluate at least every 2 years Target: < 102 cm males < 88 cm females	Not addressed
Pulse	Evaluate at least every 2 years	Not addressed
Fasting blood lipids	Evaluate at least every 5 years or every 2 years if risk factors^* are present Total cholesterol ≤ 200 mg/dl LDL: Optimal: < 100 mg/dl Near optimal: 100–129 mg/dl Borderline: 130–159 mg/dl High: 160–189 mg/dl Very high: ≥ 190 mg/dl	1 CAD risk factor: LDL < 160 mg/dl ≥ 2 CV risk factors: LDL < 130 mg/dl If CVD present or CAD risk equivalents^**: LDL < 100 mg/dl
Fasting blood glucose	Evaluate at least every 5 years or every 2 years if risk factors^* are present Target: < 100 mg/dl	Not addressed